<DOC>
	<DOCNO>NCT00834691</DOCNO>
	<brief_summary>Anemia frequent patient heart failure . Few study clearly address cause anemia patient HF . The purpose study evaluate difference blood concentration various substance relate inflammation , oxidative stress , renal function process individual 1 ) heart failure anemia , 2 ) heart failure without anemia 3 ) patient kidney disease without systolic heart failure . This study help good understand reason people heart failure anemia .</brief_summary>
	<brief_title>An Evaluation Causes Anemia Patients With Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<criteria>Groups 1 2 Age &gt; 18 year Group 1 : hemoglobin &lt; 120g/L woman &lt; 130 g/L men ( agreement WHO definition anemia ) Group 2 : hemoglobin &gt; = 120g/L woman &gt; = 130 g/L men Patients chronic HF refer specialized HF clinic , diagnosis HF least 6 month prior enrolment NYHA functional class IIIV time enrolment Patients already CHF medical therapy ( ACEI ARBs , betablockers tolerate , without digoxin , loop diuretic ) , stable dos &gt; = 1 month LVEF &lt; = 40 % within 6 month prior patient enrolment , echocardiography , radionuclide ventriculography perfusion scan , radiologic angiography Inclusion criterion group 3 Age &gt; 18 year At least moderate CRF ( eGFR &lt; 60ml/min/1,73m2 ) With without anemia LVEF &gt; = 50 % within 6 month prior patient enrolment , echocardiography , radionuclide ventriculography perfusion scan , radiologic angiography Exclusion Criteria ( group ) : Recent acute renal failure episode ( &lt; 1 month ) Red blood cell ( blood component ) transfusion EPO therapy within 3 month prior enrolment Iron , B12 folic acid supplement use treat anemia ( &lt; 3 month ) Evidence active GI bleeding Recent acute coronary syndrome decompensated HF episode ( &lt; 1 month ) Complex congenital heart disease Known malignant hematologic active neoplasia Immunosuppressive therapy , chemotherapy radiotherapy within 3 month prior enrolment Recent acute decompensation chronic inflammatory disease ( e.g . chronic inflammatory bowel disease , rheumatoid arthritis , collagen vascular disease ) within 3 month prior enrolment Recent viral bacterial syndrome ( &lt; 2 week ) Active recent viral hepatitis ( &lt; 3 month ) Pregnant woman Potential non compliance test involve protocol Incapacity provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Inflammation</keyword>
	<keyword>Oxidative stress</keyword>
	<keyword>Estimated glomerular filtration rate</keyword>
</DOC>